| Literature DB >> 28680802 |
Trung T Nguyen1,2,3, Andrew R Barber1,2, Kendall Corbin1,2,4, Wei Zhang1,2.
Abstract
The worldwide annual production of lobster was 165,367 tons valued over $3.32 billion in 2004, but this figure rose up to 304,000 tons in 2012. Over half the volume of the worldwide lobster production has been processed to meet the rising global demand in diversified lobster products. Lobster processing generates a large amount of by-products (heads, shells, livers, and eggs) which account for 50-70% of the starting material. Continued production of these lobster processing by-products (LPBs) without corresponding process development for efficient utilization has led to disposal issues associated with costs and pollutions. This review presents the promising opportunities to maximize the utilization of LPBs by economic recovery of their valuable components to produce high value-added products. More than 50,000 tons of LPBs are globally generated, which costs lobster processing companies upward of about $7.5 million/year for disposal. This not only presents financial and environmental burdens to the lobster processors but also wastes a valuable bioresource. LPBs are rich in a range of high-value compounds such as proteins, chitin, lipids, minerals, and pigments. Extracts recovered from LPBs have been demonstrated to possess several functionalities and bioactivities, which are useful for numerous applications in water treatment, agriculture, food, nutraceutical, pharmaceutical products, and biomedicine. Although LPBs have been studied for recovery of valuable components, utilization of these materials for the large-scale production is still very limited. Extraction of lobster components using microwave, ultrasonic, and supercritical fluid extraction were found to be promising techniques that could be used for large-scale production. LPBs are rich in high-value compounds that are currently being underutilized. These compounds can be extracted for being used as functional ingredients, nutraceuticals, and pharmaceuticals in a wide range of commercial applications. The efficient utilization of LPBs would not only generate significant economic benefits but also reduce the problems of waste management associated with the lobster industry. This comprehensive review highlights the availability of the global LPBs, the key components in LPBs and their current applications, the limitations to the extraction techniques used, and the suggested emerging techniques which may be promising on an industrial scale for the maximized utilization of LPBs. Graphical abstractLobster processing by-product as bioresource of several functional and bioactive compounds used in various value-added products.Entities:
Keywords: Astaxanthin; Chitin and chitosan; Lobster flavors; Lobster lipids; Lobster processing by-products; Lobster protein; Marine functional ingredients and nutraceuticals
Year: 2017 PMID: 28680802 PMCID: PMC5487823 DOI: 10.1186/s40643-017-0157-5
Source DB: PubMed Journal: Bioresour Bioprocess ISSN: 2197-4365
Fig. 1Major lobster-producing countries in the world with their contribution to the global production
Fig. 2The four main commercial lobster species in the world
Fig. 3Different by-products (heads, livers, shells, and eggs) generated from the commercial lobster processing industry
The amount of by-products generated from the different lobster processing industries
| Lobster processing industries | Types of by-products | Percentage of by-products based on starting material (%) | References |
|---|---|---|---|
| Canning of Canadian lobsters | Lobster body | 45 | Ross ( |
| Canadian lobster meat | Lobster head, hard carapace, viscera, mandibles, and gills | >75 | Tu ( |
| Brazilian lobster tails | Lobster head (cephalothorax) | 75 | Vieira et al. ( |
| Fresh meat picked from Australian rock lobster | Lobster head, shell, and viscera | 60 | Lien ( |
| High hydrostatic pressure production of American lobster meat | Lobster shells, viscera, residual meat | 75–80 | Denise and Jason ( |
Fig. 4The chemical structure of the main polymer present in lobster shell: chitin (a), and the N-deacetylation form of chitin, chitosan (b)
Total astaxanthin in by-products of lobsters compared with other crustacean species
| Source | Total astaxanthin (mg/100 g) | References |
|---|---|---|
| Shrimp ( | 4.97 | Torrissen et al. ( |
| Crawfish ( | 15.30 | Meyers and Bligh ( |
| Backs snow crab ( | 11.96 | Shahidi and Synowiecki ( |
| Lobster ( | 9.80 | Tu ( |
The different types of lobster by-products generated with their valuable components for potential areas of applications
| Lobster by-products | Functional ingredients, nutraceuticals, pharmaceuticals | Suggested application areas | References |
|---|---|---|---|
| Lobster shells (carapace) | Chitin, chitosan | Water treatment | Gustavo et al. ( |
| Chitin, chitosan, chitin-oligosaccharides, chitosan-oligosaccharide | Agriculture | Borges et al. ( | |
| Chitosan, chitosan film | Food processing and preservative | Defang et al. ( | |
| Water-soluble chitosan, chitosan particles | Pharmacy | Safitri et al. ( | |
| Chitosan film | Biomedicine | Malho et al. ( | |
| Carotenoprotein | Aquafeed | Dauphin ( | |
| Astaxanthin | Food, nutraceutical, pharmaceutical; feed additive | Auerswald and Gäde ( | |
| Proteins | Food and nutraceutical | Nguyen et al. ( | |
| Flavors and nutrient broth | Crackers, biscuits | Lien ( | |
| Lobster heads (cephalothorax) | Body meat, breast meat, and leg meat | Lobster paste, canned products | Ross ( |
| Lobster meat | Gourmet food products | Meyers and Machada ( | |
| Feed additive | Daniel ( | ||
| Lobster protein hydrolysate | Flavor enhancer, protein supplement | Vieira et al. ( | |
| Lobster roes | Raw roe | Lobster paste, canned products | Ross ( |
| Lobster livers (hepatopancreas) | Raw liver | Lobster paste, canned product | Ross ( |
| ω-3 rich lipids | Lobster oils, infused oils | Nguyen et al. ( | |
| Lobster blood (hemolymph) | Phenol oxidase | Anti-microbial proteins | Fredrick and Ravichandran ( |
| Crustin | Anti-microbial proteins | Battison et al. ( | |
| Bioactive fragment | Pharmaceutical and/or cosmetic treatment of viral and other neoplastic or pre-neoplastic mammalian tissue lesions | Bayer ( |
Fig. 5The methods used to produce chitin/chitosan derivatives with the improved functional properties
Applications of lobster chitin, chitosan, and their derivatives
| Industry | Applications | References |
|---|---|---|
| Water treatment | Removal of mercuric ion | Peniche‐Covas et al. ( |
| Removal of reactive dyes from aqueous solution | Juang et al. ( | |
| Removal of heavy metals (Cu, Hg) | Gustavo et al. ( | |
| Dye absorbents for treatment of industrial effluent | Pathiraja ( | |
| Agriculture | Seedling growth and antimycorrhizal in tomato crop | Iglesias et al. ( |
| Fungicides on plant fungal diseases | Pombo ( | |
| Amending media and seeds for inhibition of pathogen fungus growth | Borges et al. ( | |
| Inducing systemic resistance agents in tobacco plants | Falcón et al. ( | |
| Elicitors of plants defense reactions | Cabrera and Van Cutsem ( | |
| Plant growth regulators | Hipulan ( | |
| Inducing defensive agents | Cabrera et al. ( | |
| Plant protection | Ilangumaran ( | |
| Food | Organic polymer flocculants | Defang et al. ( |
| Edible or biodegradable films | Casariego et al. ( | |
| Biodegradable packages | Hudson et al. ( | |
| Fiber and nutrient supplement | Harikrishnan et al. ( | |
| Antioxidants, antimicrobials | Garcıa et al. ( | |
| Pharmaceuticals | Direct compression excipients for pharmaceutical application | Mir et al. ( |
| Co-diluent in direct compression of tablets | Mir et al. ( | |
| Water-soluble lobster chitosan salt as materials for drug carriers | Cervera et al. ( | |
| Targeted drug delivery film | Bamgbose et al. ( | |
| Bio-mouth spray for anti-halitosis | Safitri et al. ( | |
| The stability and safety of lobster chitosan salts | De la Paz et al. ( | |
| Natural additive for pharmaceuticals | Sayari et al. ( | |
| Biomedicine | Immobilization of multi-enzyme extract | Osinga et al. ( |
| Novel hybrid biomaterials for medical application | Malho et al. ( | |
| Biomimetic functional materials or epithelial treatment | Qi ( |
Several beneficial effects of astaxanthin on promoting human health
| Human health | Health benefits | References |
|---|---|---|
| Neurovascular protection | Decreases oxidation of red blood cells; decreases the chances of ischemic stroke; and improves memory and learning | Yook et al. ( |
| Eye fatigue relief | Reduces eye fatigue relieve in subjects suffering from visual display syndrome | Kajita et al. ( |
| Immune system booster | Has an immunomodulating effect, strong immune system stimulator, anti-tumor, very effective for autoimmune conditions such as rheumatoid arthritis | Chew et al. ( |
| Cardiovascular health | Improves blood lipid profiles, decreases blood pressure, offers protection from hypertension and stroke, reduces the consequences of a heart attack and vascular inflammation, reduces the area of infarction and the damage, reduces the area of infarction and the damage | Fassett and Coombes ( |
| Liver health and metabolic syndrome | Improves blood lipids and increases adiponectin, prevents fatty liver disease, reduces the risk of atherosclerotic plaque, inhibits progression of fatty liver disease, restores insulin–glucose balance, increases fat burning, and decreases inflammatory markers | Kindlund and BioReal ( |
| Diabetes and Kidneys | Reduces glucose toxicity and kidney inflammation; improves pancreatic function, insulin resistance, and insulin sensitivity | Naito et al. ( |
| Fertility | Improves sperm parameters and fertility | Comhaire et al. ( |
| Muscle resilience | Enhances power output, endurance, and recovery after exercise; prevents muscle damage and muscle atrophy | Earnest et al. ( |
| Capillary circulation | Improves blood flow and capillary integrity; reduces blood cell oxidation and risk of thrombosis | Kanazashi et al. ( |
| Anti-aging (skin cells) | Prevents UV-induced wrinkle formation, skin sagging, and age-spots; improves skin elasticity and skin dryness | Seki et al. ( |